دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Sarcopenia, obesity, and diabetes – The metabolic conundrum trifecta
doi : 10.1016/j.dsx.2022.102656
Volume 16, Issue 11, November 2022, 102656
Frequency of iron deficiency anemia in type 2 diabetes - Insights from tertiary diabetes care centres across India
Rajendra Pradeepa a, Lal Shreya b , Ranjit Mohan Anjana a, Saravanan Jebarani a,Nithyanantham Kamal Raj a, Madhan Srinivasan Kumar a, Parthasarathy Jayaganesh a,Onkar C. Swami b, Viswanathan Mohan
doi : 10.1016/j.dsx.2022.102632
Volume 16, Issue 11, November 2022, 102632
To study the frequency of iron deficiency anemia (IDA) in individuals with type 2 diabetes mellitus (T2DM) seen at tertiary diabetes care centres across India.
Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting
Sanobia Yousuf a, Muhammad Yakoob Ahmedani
doi : 10.1016/j.dsx.2022.102633
Volume 16, Issue 11, November 2022, 102633
To explore efficacy and safety of empagliflozin in people with type2 diabetes during Ramadan fasting
Dose-dependent efficacy and safety of licogliflozin on obese adults: A systematic review and meta-analysis of randomized controlled trials
Alaa Mohamed Zaki a, *, 1, Dina Essam Abo-Elnour a, 1, Yomna Emad Abdalla a,Rehab Yosri Hassan b, Moaz Khaled Salama a, Toka Elboraay a,Ibrahim Abdelmonaem Abdelhaleem
doi : 10.1016/j.dsx.2022.102657
Volume 16, Issue 11, November 2022, 102657
Licogliflozin is a dual SGLT1/2 inhibitor acting on the intestine and kidney by reducing glycemic and calorie content. We aimed to determine the efficacy and safety of licogliflozin on Anthropometric measurements and cardiometabolic parameters in obese participants.
Bladder cancer with pioglitazone: A case–control study
Bhanu Malhotra a, Priya Hiteshi a, Persis Khalkho a, Ritu Malik d, Sanjay Kumar Bhadada a,Anil Bhansali a, Nusrat Shafiq b, Sameer Malhotra b, Narendra Kumar c , Rajesh Rajput d,Ashu Rastogi
doi : 10.1016/j.dsx.2022.102637
Volume 16, Issue 11, November 2022, 102637
Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes.
Association between serum 25 (OH) D levels and depression symptoms in adults with prediabetes
Thi Quynh Chi Vu a, b, *, Quoc Kham Tran c , Kaijun Niu
doi : 10.1016/j.dsx.2022.102642
Volume 16, Issue 11, November 2022, 102642
Depression symptoms are a significant risk factor for prediabetes-related diabetes, and low vitamin D levels are connected with depression symptoms. The goal of this study is to examine the association between vitamin D and depression symptoms in prediabetic persons.
An association between the sarcolemmal membrane-associated protein gene and microvascular endothelial diabetic retinopathy in patients with type 2 diabetes mellitus: A preliminary case control study
Hanan Mohamed Farhan a , Mahmoud Nassar b, *, Mansour Hassan Ahmed c , Khadiga Abougabal a , Niveen Abd Elazim Taha
doi : 10.1016/j.dsx.2022.102653
Volume 16, Issue 11, November 2022, 102653
Diabetic retinopathy (DR) is one of the most common microvascular diabetic complications. Sarcolemmal membrane-associated protein (SLMAP) has been implicated in playing a role in microvascular endothelial dysfunction. This study aimed to assess the significance of SLMAP rs17058639CÂ >Â T gene polymorphism among patients with type 2 diabetes mellitus (T2DM) and its relevance to microvascular endothelial diabetic retinopathy.
Knowledge of diabetes and the practice of diabetes self-management during Ramadan fasting among patients with type 2 diabetes in Malaysia
Salimah Japar a, d, *, Swee Leong Ong b, Zamri Muhamed c , Kensaku Fukunaga d,Toshihiro Kobayashi d , Hitomi Imachi d , Seisuke Sato d, Takanobu Saheki d,Tomohiro Ibata d, Takafumi Yoshimura d, Kim Lam Soh a, Koji Murao
doi : 10.1016/j.dsx.2022.102655
Volume 16, Issue 11, November 2022, 102655
To assess the level of diabetes knowledge and its association with diabetes self-management practices during Ramadan fasting among patients with type 2 diabetes (T2D).
Efficacy and safety of tirzepatide as novel treatment for type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials
Hikmat Permana a, Theo Audi Yanto b, Timotius Ivan Hariyanto
doi : 10.1016/j.dsx.2022.102640
Volume 16, Issue 11, November 2022, 102640
This study aims to explore the efficacy and safety of tirzepatide for patients with type 2 diabetes (T2D).
Molecular mechanisms interlinking biological clock and diabetes mellitus: Effective tools for better management
Chandrasekaran Sankaranarayanan, Perumal Subramanian
doi : 10.1016/j.dsx.2022.102639
Volume 16, Issue 11, November 2022, 102639
Advances in circadian biology have delineated the link between perturbed biological clock and metabolic diseases. Circadian disturbances are associated with the onset, progression and severity of diabetes mellitus.
Clinical outcomes of off-pump coronary artery bypass graft in patients with diabetes and non-diabetics: A systematic review and meta-analysis
Fatemeh Behesht aeen a, 1, Reza Pakzad b, 1, Zahra Tayebi c , Razie Iloon Kashkooli a,Fatemeh Abdi
doi : 10.1016/j.dsx.2022.102643
Volume 16, Issue 11, November 2022, 102643
Diabetes mellitus is a prevalent risk factor for developing coronary artery disease which worsens the clinical outcomes of patients undergoing coronary artery bypass grafting (CABG). This study aimed to determine the clinical outcomes of patients with diabetes and non-diabetic patients who underwent off-pump CABG surgery.
Global research in sarcopenia: High-cited papers, research institutions, funding agencies and collaborations, 1993–2022
Raju Vaishya a, *, Brij Mohan Gupta b, Anoop Misra c, d, e, Ghouse Modin Mamdapurj f ,Abhishek Vaish
doi : 10.1016/j.dsx.2022.102654
Volume 16, Issue 11, November 2022, 102654
This bibliometric analysis aims to analyze the high-cited papers (HCPs), those which have received >100 citations) on Sarcopenia to provide insight into publication performances and research characteristics of the literature.
An economic evaluation of diabetes mellitus in India: A systematic review
Shreyaswi Sathyanath a, Rashmi Kundapur b, R. Deepthi c , Santhosh N. Poojary d, *,Sathvik Rai d, Bhavesh Modi e , Deepak Saxena
doi : 10.1016/j.dsx.2022.102641
Volume 16, Issue 11, November 2022, 102641
Approximately 88 million people throughout Southeast Asia have diabetes, of which 77 million reside in India. India had an annual estimated diabetes treatment cost of Rs.10,000 to 12,000 crore in 2003, which is likely to rise to as high as Rs. 1,26,000 crores by 2025.
